Effects of Antioxidant and Nitric Oxide on Chemokine Production in TNF-α-stimulated Human Dermal Microvascular Endothelial Cells
Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox...
Saved in:
Published in | Free radical research Vol. 38; no. 5; pp. 473 - 480 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
01.05.2004
|
Subjects | |
Online Access | Get full text |
ISSN | 1071-5762 1029-2470 |
DOI | 10.1080/1071576042000209826 |
Cover
Abstract | Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-κB) induced by TNF-α (10 ng/ml). Treatment with TNF-α for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-κB were induced by TNF-α for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-α are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-κB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases. |
---|---|
AbstractList | Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-kappaB) induced by TNF-alpha (10 ng/ml). Treatment with TNF-alpha for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-kappaB were induced by TNF-alpha for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-alpha are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-kappaB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases.Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-kappaB) induced by TNF-alpha (10 ng/ml). Treatment with TNF-alpha for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-kappaB were induced by TNF-alpha for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-alpha are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-kappaB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases. Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-κB) induced by TNF-α (10 ng/ml). Treatment with TNF-α for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-κB were induced by TNF-α for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-α are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-κB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases. Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-kappaB) induced by TNF-alpha (10 ng/ml). Treatment with TNF-alpha for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-kappaB were induced by TNF-alpha for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-alpha are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-kappaB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases. |
Author | Tsukahara, Hirokazu Mayumi, Mitsufumi Hiraoka, Masahiro Ohshima, Yusei Sato, Shuko Jiang, Mi-Zu Todoroki, Yukiko |
Author_xml | – sequence: 1 givenname: Mi-Zu surname: Jiang fullname: Jiang, Mi-Zu email: htsuka@fmsrsa.fukui-med.ac.jp – sequence: 2 givenname: Hirokazu surname: Tsukahara fullname: Tsukahara, Hirokazu – sequence: 3 givenname: Yusei surname: Ohshima fullname: Ohshima, Yusei – sequence: 4 givenname: Shuko surname: Sato fullname: Sato, Shuko – sequence: 5 givenname: Yukiko surname: Todoroki fullname: Todoroki, Yukiko – sequence: 6 givenname: Masahiro surname: Hiraoka fullname: Hiraoka, Masahiro – sequence: 7 givenname: Mitsufumi surname: Mayumi fullname: Mayumi, Mitsufumi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15293554$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1u1TAQhS1URH_gCZCQV-wC_kmcZINU3d62SKXtoqwtxx6rBscutgPtso_UF-GZ8NUtLFDVla2Z7xzNnNlHOyEGQOgtJR8oGchHSnra9YK0jBDCyDgw8QLtUcLGhrU92dn8e9pUhO2i_Zy_EUJ52_Wv0C7t2Mi7rt1D92trQZeMo8WHobh464wKBatg8LkryWl8UUuAY8Cra5jjdxcAX6ZoFl3pgF3AV-fHze-HJhc3L14VMPh0mVXAR5Bm5fEXp1P8qbKuzYTXwcRyDd7Vzgq8z6_RS6t8hjeP7wH6ery-Wp02Zxcnn1eHZ43mAy3NoEBA3dcOfAKhdTsx0wsxsmnqBmhBiZ5SU8uUj6Ylk6ZWUDFO1miYWsX5AXq_9b1J8ccCucjZZV0nUAHikqUQfcfJQCv47hFcphmMvEluVulO_g2tAuMWqHvlnMBK7YrapFGScl5SIjcHkk8cqGr5f9p_9s-qPm1VLthYQ_0VkzeyqDsfk00qaJclf87gDwPnpys |
CitedBy_id | crossref_primary_10_1016_j_carrev_2009_12_001 crossref_primary_10_1016_j_atherosclerosis_2010_05_029 crossref_primary_10_1016_j_cardiores_2006_12_018 crossref_primary_10_1007_s12272_009_1122_4 |
Cites_doi | 10.1001/archderm.138.8.1027 10.1146/annurev.immunol.14.1.649 10.1016/S0891-5849(98)00094-X 10.1016/S0002-9440(10)64416-1 10.1016/S0923-1811(00)00138-9 10.1161/01.ATV.14.10.1665 10.1038/sj.bjp.0704463 10.1016/S0891-5849(00)00218-5 10.1007/s004030000134 10.1016/S0891-5849(00)00482-2 10.1128/IAI.69.3.1265-1272.2001 10.1053/gast.2000.8538 10.1006/cyto.2002.0888 10.1016/S0891-5849(00)00251-3 10.1002/jlb.63.6.732 10.1016/S1367-5931(00)00113-7 10.1016/S0955-2863(01)00186-3 10.1007/s00403-001-0276-9 10.1074/jbc.M109358200 10.1182/blood.V88.9.3482.bloodjournal8893482 10.1016/S0165-2478(02)00208-0 10.1073/pnas.93.17.9114 10.1042/bj3470265 10.1006/bbrc.2000.3170 10.1111/j.1365-2133.1997.tb08740.x 10.1006/clim.1999.4829 10.1515/BC.1999.109 10.1016/S0006-2952(99)00296-8 10.1161/01.RES.76.6.980 10.1111/1523-1747.ep12289711 |
ContentType | Journal Article |
Copyright | 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004 |
Copyright_xml | – notice: 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1080/1071576042000209826 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1029-2470 |
EndPage | 480 |
ExternalDocumentID | 15293554 10_1080_1071576042000209826 11228567 |
Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 00X 03L 0BK 0R~ 29H 30N 36B 4.4 53G 5GY 5VS A8Z AAGME AAJMT AALDU AALIY AAMIU AAPUL AAPXX AAQRR ABCCY ABDBF ABFIM ABJNI ABJYH ABLIJ ABLKL ABPAQ ABXUL ABXYU ACDHJ ACGEJ ACGFS ACTIO ACUHS ADCVX ADGTB ADOPC ADRBQ ADXPE ADYSH AEISY AENEX AEOZL AEPSL AEYOC AFKVX AFOSN AFRVT AGDLA AHDZW AIJEM AIYEW AJWEG AKBVH AKOOK ALMA_UNASSIGNED_HOLDINGS ALQZU AMPGV AQRUH AURDB AWYRJ BABNJ BFWEY BLEHA CAG CCCUG COF CS3 CWRZV DGEBU DKSSO DU5 EAP EBC EBD EBS EJD EMB EMK EMOBN EPL EST ESX F5P H13 HZ~ JEPSP KRBQP KSSTO KWAYT KYCEM M44 M4Z MM. O9- P2P PCLFJ RNANH ROSJB RTWRZ SV3 TBQAZ TDBHL TFDNU TFL TFT TFW TQWBC TTHFI TUROJ TUS V1S ZGOLN ZXP ~1N .HR AAGDL AAHIA AAOAP AAYXX ABFMO ABTAA ACBBU ACQMU ADGTR AFDYB AFFNX APNXG CITATION HGUVV LJTGL NUSFT OWHGL RNS Z0Y CGR CUY CVF ECM EIF NPM 7X8 TASJS |
ID | FETCH-LOGICAL-c381t-8ae6e157f83be6cc4b2d76692bb58e4ea6711dc4b139d40bc1f6169bfdceb4a33 |
ISSN | 1071-5762 |
IngestDate | Thu Sep 04 22:25:21 EDT 2025 Wed Feb 19 01:54:41 EST 2025 Tue Jul 01 02:15:26 EDT 2025 Thu Apr 24 23:03:08 EDT 2025 Tue May 20 10:47:38 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c381t-8ae6e157f83be6cc4b2d76692bb58e4ea6711dc4b139d40bc1f6169bfdceb4a33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 15293554 |
PQID | 66753081 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | crossref_citationtrail_10_1080_1071576042000209826 crossref_primary_10_1080_1071576042000209826 pubmed_primary_15293554 informaworld_taylorfrancis_310_1080_1071576042000209826 proquest_miscellaneous_66753081 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2004-05-01 |
PublicationDateYYYYMMDD | 2004-05-01 |
PublicationDate_xml | – month: 05 year: 2004 text: 2004-05-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Free radical research |
PublicationTitleAlternate | Free Radic Res |
PublicationYear | 2004 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | Spiecker M. (CIT0018) 1998; 63 Huber M.A. (CIT0009) 2002; 277 Andoh A. (CIT0013) 2000; 119 Cho N.H. (CIT0006) 2001; 69 Janssen-Heininger Y.M.W. (CIT0025) 2000; 28 Baldwin A.S.J (CIT0010) 1996; 14 Nemeth Z.H. (CIT0015) 2003; 85 Sebastiani S. (CIT0004) 2002 Bowie A (CIT0024) 2000 Goebeler M. (CIT0008) 1997; 108 Wetzler C. (CIT0020) 2000; 274 Khan B.V. (CIT0030) 1996; 93 Spandau U. (CIT0005) 2002; 138 Cooper P.J. (CIT0007) 2000; 95 Ignarro L.J. (CIT0032) 1981; 218 Rowe A. (CIT0031) 1997; 136 Cuzzocrea S. (CIT0012) 2002; 135 Schroder J.M. (CIT0022) 1999; 380 Fitzhugh A.L. (CIT0034) 2000; 28 Munoz C. (CIT0011) 1996; 88 Uchi H. (CIT0023) 2000; 24 Frank S. (CIT0003) 2000; 347 Cascieri M.A. (CIT0001) 2000; 4 Mathews W.R. (CIT0033) 1993; 267 Grandjean-Laquerriere A. (CIT0016) 2002; 18 Grisham M.B. (CIT0017) 1998; 25 Anderegg U. (CIT0002) 2000; 292 Lee Y.W. (CIT0014) 2001; 12 Kim C.H. (CIT0029) 2003; 384 Giustizieri ML. (CIT0019) 2002 Weber C. (CIT0028) 1994; 14 Rahman A. (CIT0027) 1998; 19 Zeiher AM. (CIT0021) 1995 Fuchs J. (CIT0026) 2001; 30 |
References_xml | – volume: 138 start-page: 1027 year: 2002 ident: CIT0005 publication-title: Arch. Dermatol doi: 10.1001/archderm.138.8.1027 – volume: 218 start-page: 739 year: 1981 ident: CIT0032 publication-title: J. Pharmacol. Exp. Ther – volume: 14 start-page: 649 year: 1996 ident: CIT0010 publication-title: Annu. Rev. Immunol doi: 10.1146/annurev.immunol.14.1.649 – volume: 25 start-page: 404 year: 1998 ident: CIT0017 publication-title: Free Radic. Biol. Med doi: 10.1016/S0891-5849(98)00094-X – start-page: 1409 year: 2002 ident: CIT0019 publication-title: Am. J. Pathol doi: 10.1016/S0002-9440(10)64416-1 – volume: 24 start-page: S29—S38 year: 2000 ident: CIT0023 publication-title: J. Dermatol. Sci doi: 10.1016/S0923-1811(00)00138-9 – volume: 14 start-page: 1665 year: 1994 ident: CIT0028 publication-title: Arterioscler. Thromb doi: 10.1161/01.ATV.14.10.1665 – volume: 135 start-page: 496 year: 2002 ident: CIT0012 publication-title: Br. J. Pharmacol doi: 10.1038/sj.bjp.0704463 – volume: 267 start-page: 1529 year: 1993 ident: CIT0033 publication-title: J. Pharmacol. Exp. Ther – volume: 28 start-page: 1317 year: 2000 ident: CIT0025 publication-title: Free Radic. Biol. Med doi: 10.1016/S0891-5849(00)00218-5 – volume: 292 start-page: 341 year: 2000 ident: CIT0002 publication-title: Arch. Dermatol. Res doi: 10.1007/s004030000134 – volume: 19 start-page: L533—L544 year: 1998 ident: CIT0027 publication-title: Physiol – volume: 30 start-page: 337 year: 2001 ident: CIT0026 publication-title: Free Radic. Biol. Med doi: 10.1016/S0891-5849(00)00482-2 – volume: 69 start-page: 1265 year: 2001 ident: CIT0006 publication-title: Infect. Immun doi: 10.1128/IAI.69.3.1265-1272.2001 – volume: 119 start-page: 211 year: 2000 ident: CIT0013 publication-title: Gastroenterology doi: 10.1053/gast.2000.8538 – volume: 18 start-page: 168 year: 2002 ident: CIT0016 publication-title: Cytokine doi: 10.1006/cyto.2002.0888 – volume: 28 start-page: 1463 year: 2000 ident: CIT0034 publication-title: Free Radic. Biol. Med doi: 10.1016/S0891-5849(00)00251-3 – volume: 63 start-page: 732 year: 1998 ident: CIT0018 publication-title: J. Leukoc. Biol doi: 10.1002/jlb.63.6.732 – volume: 4 start-page: 420 year: 2000 ident: CIT0001 publication-title: Curr. Opin. Chem. Biol doi: 10.1016/S1367-5931(00)00113-7 – volume: 12 start-page: 648 year: 2001 ident: CIT0014 publication-title: J. Nutr. Biochem doi: 10.1016/S0955-2863(01)00186-3 – start-page: 552 year: 2002 ident: CIT0004 publication-title: Arch. Dermatol. Res doi: 10.1007/s00403-001-0276-9 – volume: 277 start-page: 1268 year: 2002 ident: CIT0009 publication-title: J. Biol. Chem doi: 10.1074/jbc.M109358200 – volume: 88 start-page: 3482 year: 1996 ident: CIT0011 publication-title: Blood doi: 10.1182/blood.V88.9.3482.bloodjournal8893482 – volume: 85 start-page: 41 year: 2003 ident: CIT0015 publication-title: Immunol. Lett doi: 10.1016/S0165-2478(02)00208-0 – volume: 384 start-page: 143 year: 2003 ident: CIT0029 publication-title: Biol. Chem – volume: 93 start-page: 9114 year: 1996 ident: CIT0030 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.93.17.9114 – volume: 347 start-page: 265 year: 2000 ident: CIT0003 publication-title: Biochem. J doi: 10.1042/bj3470265 – volume: 274 start-page: 689 year: 2000 ident: CIT0020 publication-title: Biochem. Biophys. Res. Commun doi: 10.1006/bbrc.2000.3170 – volume: 136 start-page: 18 year: 1997 ident: CIT0031 publication-title: Br. J. Dermatol doi: 10.1111/j.1365-2133.1997.tb08740.x – volume: 95 start-page: 51 year: 2000 ident: CIT0007 publication-title: Clin. Immunol doi: 10.1006/clim.1999.4829 – volume: 380 start-page: 889 year: 1999 ident: CIT0022 publication-title: Biol. Chem doi: 10.1515/BC.1999.109 – start-page: 13 year: 2000 ident: CIT0024 publication-title: Biochem. Pharmacol doi: 10.1016/S0006-2952(99)00296-8 – start-page: 980 year: 1995 ident: CIT0021 publication-title: Circ. Res doi: 10.1161/01.RES.76.6.980 – volume: 108 start-page: 445 year: 1997 ident: CIT0008 publication-title: J. Invest. Dermatol doi: 10.1111/1523-1747.ep12289711 |
SSID | ssj0013457 |
Score | 1.7575701 |
Snippet | Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 473 |
SubjectTerms | Antineoplastic Agents - pharmacology Antioxidants Antioxidants - pharmacology Chemokines Chemokines - metabolism Dermis - blood supply Endothelial activation Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism Humans Microcirculation - cytology NF-kappa B - metabolism Nitric oxide Nitric Oxide - pharmacology Nuclear factor kappa B Oxidation-Reduction Reactive oxygen species Tumor Necrosis Factor-alpha - pharmacology |
Title | Effects of Antioxidant and Nitric Oxide on Chemokine Production in TNF-α-stimulated Human Dermal Microvascular Endothelial Cells |
URI | https://www.tandfonline.com/doi/abs/10.1080/1071576042000209826 https://www.ncbi.nlm.nih.gov/pubmed/15293554 https://www.proquest.com/docview/66753081 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELagKwEXBAss5ekDt2LIw3kdV0urarXtHmhF2UtkJ44atU1WbSOhPfPDGT-apFCWxyWKnNqNPJ8n4_E3Mwi9owmV5EGbMBGlhAZWRFgibOI6ieMGXhTRSAYKj8b-cErPZ96soQ6p6JIt_5DcHIwr-R-pQhvIVUbJ_oNk60GhAe5BvnAFCcP1r2Tcb8gYTLIWv-UpM5RxWKmSIy-bhDwQANmsyoU0Ka91jlfDcZyMB0TF2xJY6ytZywssUF24L5VKe9lbScpeTVgVRSpjtpbS0S6d_pu2dTtYC9FbM330Y9II1e7m89y4pkc5uapqj8GmWjCZNFp9A_N1uWA39cPL-Waer9Sjr9VG5LU7iKniT73P82pR7vktaMMSNKoWjBvi_aSL3bCFOa-lWKkuePKLwtcMSTkWDAUKSB2tRqFzIL32-DIeTC8u4kl_NrmLjpwAjK0OOjodfrr60hw8UZUctn65XaKq0Pp44E_2jJm9VLe_37Aow2XyCD00Ow58quHzGN0RxTG6f7Yr9HeM7o0Mv-IJ-m4QhcsMtxAF9ynWiMIKUbgscI0o3CAK5wU-hCisEIU1ovAeonALUVgh6imaDvqTsyExdTpIAvbeloRM-AKmJgtdLvwkodxJYXIjh3MvFFQwP7DtFJpht5FSiyd25tt-xLM0EZwy132GOkVZiOcIczB4oSXwGHwnbJFFlstCMKKFZ3GfhayLnN2Ex4lJYi9rqSxj2-S6PSClLnpfd7rWOVxu_3nQlmS8Va6zTNe5id1be77dCT0GGco5Y4Uoq03sw77cBeu7i040FpoX8RxZ4oC--GPfl-hBs45eoc52XYnXYBFv-RuD4h86nrbe |
linkProvider | Library Specific Holdings |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELWgSLQXPgoty1d94IirOHac-FgtXS3QDRy2Um-R7TjSqiFBbFZC3PhJ_BF-EzNxQltUeoBTJCtjx_HYfsk8vyHklXQSyYOcGa9LJtNIM-M8ZyJ2sUgTraXGg8KLXM1P5buz5OzSKX6kVeI3dBWEIvq1Gic3_oweKXFwTTngZPC3PpKmASLfJncSAONI6hNRfhFHkL3WJxowsIhH3aHrK7myN11RLv07_uz3odl9YsYeBPrJ-eGms4fu2x_ijv_TxQfk3gBS6VHwqofklm92yfZ0zA23S-4uhpD8I_I96B-vaVvRI6ROfl2VMFoUmqb5CvX_6Qco8rRtKNbQnoMZ_RiEZsEp6Kqhy3zGfv5gsNp8wmxivqR9bIG-wW2jpgskDY6UWXrclHhqrIaJQ6e-rtePyenseDmdsyGvA3OADzqWGa889K7KhPXKOWnjMlVKx9YmmZfeqJTzEooBnZYyso5Xiittq9J5K40Qe2SraRv_hFALAAlK0sTAusJ9pSNhMgBdPomsMpmZkHgc0cINoueYe6Mu-KCNes2LnpDXv40-B82Pm29PL7tK0fW_WqqQF6UQN1oejF5VwABiqMY0vt2sCwXfcQLQ2oTsB2e7eJAkRkl8-fSfWz0g2_Pl4qQ4eZu_f0Z2AhUJGZzPyVb3ZeNfAMrq7Mt-Iv0CoOIYew |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB1BkQoXCoXC8lUfOOIqjh0nPlbbrsrHhh5aqbdgO460akgqNiuh3vqT-CP8JsZx0lJUeoBTJCvjxPHYfs48vwF4K6zw5EFGtVMlFWmkqLaOUR7bmKeJUkL5g8LzXB4ciw8nycmQ53Q50Cr9HroKQhH9XO0H91lZjYw4vKYMYTK6Wx9IU4iQ78I9GXHlxfN5lF-FEUQv9ekNKFrEo-zQzZVcW5quCZf-HX72y9BsA76MDQjsk9OdVWd27Pkf2o7_0cJH8HCAqGQ3-NRjuOOaTbg_HTPDbcL6fAjIP4GLoH68JG1Fdj1x8vuixL4i-GSSL7z6P_mMRY60DfE1tKdoRg6DzCy6BFk05Cif0Z8_KM41X30uMVeSPrJA9vyiUZO5pwyOhFmy35T-zFiNw4ZMXV0vn8LxbP9oekCHrA7UIjroaKaddNi6KuPGSWuFictUShUbk2ROOC1TxkosRmxaishYVkkmlalK64zQnG_BWtM27jkQg_AIS9JE46zCXKUirjOEXC6JjNSZnkA8dmhhB8lzn3mjLtigjHrDh57Au0ujs6D4cfvt6e-eUnT9j5YqZEUp-K2W26NTFdiBPlCjG9euloXEXRxHrDaBZ8HXrl4kib0gvnjxz0_dhvXDvVnx6X3-8SU8CDwkT998BWvdt5V7jRCrM2_6YfQLLRYXKA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+antioxidant+and+nitric+oxide+on+chemokine+production+in+TNF-alpha-stimulated+human+dermal+microvascular+endothelial+cells&rft.jtitle=Free+radical+research&rft.au=Jiang%2C+Mi-Zu&rft.au=Tsukahara%2C+Hirokazu&rft.au=Ohshima%2C+Yusei&rft.au=Sato%2C+Shuko&rft.date=2004-05-01&rft.issn=1071-5762&rft.volume=38&rft.issue=5&rft.spage=473&rft_id=info:doi/10.1080%2F1071576042000209826&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1071-5762&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1071-5762&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1071-5762&client=summon |